The END Fund
The END Fund
Explore linked clinical trials.1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Moxidectin Versus Ivermectin as Mass Drug Administration for the Control of Onchocerciasis and Other Neglected Tropical Diseases | Adenophorea Infections, Enoplea infectious disease, Hookworm Infections, Infections, Nematoda infectious disease, Secernentea Infections, Skin and Connective Tissue Diseases, Spirurida Infections, Strongylida infectious disease, filariasis, helminthiasis, mite infestation, onchocerciasis, parasitic ectoparasitic infectious disease, parasitic infectious disease, parasitic skin disorder, scabies, skin disorder, skin disorder caused by infection, trichuriasis | Recruiting | Phase 4 | 2025-11-21 | NCT07145736 |